Abstract
Background
Patients undergoing surgical procedures are usually asked to discontinue any anticoagulant/antiplatelet therapy and delay surgery for at least 5 days to reduce the risk of major bleeding and spinal hematoma.
Aim
The purpose of this study was to determine if this strategy is suitable for patients on anticoagulant/antiplatelet therapy affected by a hip fracture, evaluating the effect of anticoagulant/antiplatelet therapy and surgical timing on mortality and complication rates for patients affected by a hip fracture.
Patients and methods
We performed an observational study on patients referring to our hospital for a hip fracture. We evaluated patients on warfarin, ticlopidine, and aspirin therapy matched to patients not on anticoagulant or antiplatelet therapy, out of 875 consecutive patients treated for a hip fracture in a 5-year period. Blood loss, blood transfusions, length of hospitalization, walking ability, complications, and mortality at 1 year of follow-up were recorded. Kruskal–Wallis, Mann–Whitney U, and logistic regression statistical tests were performed.
Results
Patients on warfarin therapy operated more than 5 days after admission showed significantly higher complication and mortality rates compared to all other patients. Two critical factors were identified: warfarin therapy and excessive time to surgery; these factors are not significant if taken alone, while they become a high-risk factor if taken together.
Conclusion
The “discontinue drug, and delay surgery” strategy is not suitable for patients on anticoagulant (warfarin) therapy affected by a hip fracture.
Similar content being viewed by others
References
Rae HC, Harris IA, McEvoy L, Todorova T. Delay to surgery and mortality after hip fracture. ANZ J Surg. 2007;77:889–91.
Koval KJ, Zuckerman JD. Hip fractures: A practical guide to management. New York: Springer-Verlag; 2000.
Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am. 2005;87:483–9.
Orosz GM, Magaziner J, Hannan EL, Morrison RS, Koval K, Gilbert M, McLaughlin M, Halm EA, Wang JJ, Litke A, Silberzweig SB, Siu AL. Association of timing of surgery for hip fracture and patient outcomes. JAMA. 2004;291(14):1738–43.
Siegmeth AW, Gurusamy K, Parker MJ. Delay to surgery prolongs hospital stay in patients with fractures of the proximal femur. J Bone Joint Surg Br. 2005;87:1123–6.
Al-Rashid M, Parker MJ. Anticoagulation management in hip fracture patients on warfarin. Injury. 2005;36:1311–5.
Ezekowitz MD, Netrebko PI. Anticoagulation in management of atrial fibrillation. Curr Opin Cardiol. 2003;18:26–31.
Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352:1167–71.
Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition—2005 update. Br J Haematol. 2006;132:277–85.
Salamat A, Seaton J, Watson HG. Impact of introducing guidelines on anticoagulant reversal. Transfus Med. 2005;15:99–105.
Tharmarajah P, Pusey J, Keeling D, Willett K. Efficacy of warfarin reversal in orthopedic trauma surgery patients. J Orthop Trauma. 2007;21(1):26–30.
Hantler C, Despotis GJ, Sinha R, Chelly JE. Guidelines and alternatives for neuraxial anesthesia and venous thromboembolism prophylaxis in major orthopedic surgery. J Arthroplasty. 2004;19(8):1004–16.
Armstrong RF, Addy V, Breivik H. Epidural and spinal anaesthesia and the use of anticoagulants. Hosp Med. 1999;60(7):491–6.
Manning BJ, O’Brien N, Aravindan S, Cahill RA, McGreal G, Redmond HP. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury. 2004;35:121–4.
Narchi P. Spinal anaesthesia and the use of anticoagulants. Best Pract Res Clin Anaesthesiol. 2003;17(3):443–9.
Spandorfer J. The management of anticoagulation before and after procedures. Med Clin North Am. 2001;85(5):1109–16.
Bertini L, Savoia G, De Nicola A, Ivani G, Gravino E, Albani A, Alemanno F, Barbati A, Borghi B, Borrometi F, Casati A, Celleno D, Ciaschi A, Corcione A, De Negri P, Di Benedetto P, Evangelista M, Fanelli G, Grossi P, Loreto M, Margaria E, Mastronardi P, Mattia C, Nicosia F, Nolli M, Rutili A, Santangelo E, Sucre J, Tagariello V, Varrassi G, Paoletti F, Tufano R. SIAARTI guidelines for safety in locoregional anaesthesia. Minerva Anestesiol. 2006;72(9):689–722.
du Breuil AL, Umland EM. Outpatient management of anticoagulation therapy. Am Fam Physician. 2007;75(7):1031–42.
[No authors listed]. Guidelines on oral anticoagulation: third edition. Br J Haematol. 1998;101(2):374–87.
Jaffer AK, Brotman DJ, Chukwumerije N. When patients on warfarin need surgery. Cleve Clin J Med. 2003;70(11):973–84.
Dillon MF, Collins D, Rice J, Murphy PG, Nicholson P, Mac Elwaine J. Preoperative characteristics identify patients with hip fractures at risk of transfusion. Clin Orthop Relat Res. 2005;439:201–6.
Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47(260):583–621.
Hollander M, Wolfe DA. Nonparametric statistical methods. 2nd ed. New York: Wiley; 1999.
Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd ed. Oxford: Blackwell Science Ltd.; 2003.
Novack V, Jotkowitz A, Etzion O, Porath A. Does delay in surgery after hip fracture lead to worse outcomes? A multicenter survey. Int J Qual Health Care. 2007;19:170–6.
Aharonoff GB, Koval KJ, Skovron ML, Zuckerman JD. Hip fractures in the elderly: predictors of one year mortality. J Orthop Trauma. 1997;11:162–5.
Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg. 1996;82:13–21.
Travis S, Wray R, Harrison K. Perioperative anticoagulant control. Br J Surg. 1989;76:1107–8.
Sandset PM. Editorial on: perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thrombosis Res. 2003;108(1):1–2.
Enneking FK, Benzon H. Oral anticoagulants and regional anesthesia: a perspective. Reg Anesth Pain Med. 1998;23:140–5.
Horlocker TT. Low molecular weight heparin and neuraxial anesthesia. Thromb Res. 2001;101:V141–54.
Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994;79:1165–77.
Kawaguchi S, Tokutomi S. A case of epidural hematoma associated with epidural catheterization which occurred on 12th days after the last medication of ticlopidine hydrochloride. Masui. 2002;51(5):526–8.
Sauer W, Schwagmeier R, Nolte H. Long-term medication with acetylsalicylic acid—a problem in regional anesthesia? Anaesthesist. 1992;41(8):489–93.
Gerhart TN, Yett HS, Robertson LK, Lee MA, Smith M, Salzman EW. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial. J Bone Joint Surg Am. 1991;73(4):494–502.
Pullarkat VA, Kalapura T, Pincus M, Baskharoun R. Intraspinal hemorrhage complicating oral anticoagulant therapy: an unusual case of cervical hematomyelia and a review of the literature. Arch Intern Med. 2000;160:237–40.
Bottle A, Aylin P. Mortality associated with delay in operation after hip fracture: observational study. BMJ. 2006;332:947–51.
Von Meibom N, Gilson N, Dhapre A, Davis B. Operative delay for fracture of the hip: a two-centre prospective study. J Bone Joint Surg Br. 2007;89(1):77–9.
Strömberg L, Ohlén G, Nordin C, Lindgren U, Svensson O. Postoperative mental impairment in hip fracture patients. A randomized study of reorientation measures in 223 patients. Acta Orthop Scand. 1999;70:250–5.
Clague JE, Craddock E, Andrew G, Horan MA, Pendleton N. Predictors of outcome following hip fracture. Admission time predicts length of stay and in-hospital mortality. Injury. 2002;33:1–6.
Royal College of Physicians. Fractured neck of femur: prevention and management. London: Royal College of Physicians; 1989.
Morritt DG, Morritt AN, Kelley SP, Stone MH. Blood ordering protocol based on proposed surgical implant in fractured neck of femur patients. Ann R Coll Surg Engl. 2005;87(6):445–8.
Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. J Bone Joint Surg Br. 2006;88(8):1053–9.
Watson HG, Baglin T, Laidlaw SL, Makris M, Preston FE. A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol. 2001;115:145–9.
Bansal R, Watson DK. Surgical delay in acute admissions on warfarin: are we doing enough? Int J Clin Pract. 2005;59(11):1283–8.
Hanley JP. Warfarin reversal. J Clin Pathol. 2004;57:1132–9.
Shields RC, McBane RD, Kuiper JD, Li H, Heit JA. Efficacy and safety of intravenous phytonadione (Vitamin K1) in patients on long-term oral anticoagulant therapy. Mayo Clin Proc. 2001;76:260–6.
Crowther MA, Donovan D, Harrison L, McGinnis J, Ginsberg J. Low-dose oral Vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost. 1998;79:1116–8.
Acknowledgments
The authors wish to thank Dr. Andrea Evangelista (SC Epidemiologia dei Tumori—COES, Ospedale Molinette, Torino, Italy) for his helpful supervision of the statistical analyses.
Conflict of interest
The authors declare that they have no conflict of interest related to this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dettoni, F., Castoldi, F., Giai Via, A. et al. Influence of timing and oral anticoagulant/antiplatelet therapy on outcomes of patients affected by hip fractures. Eur J Trauma Emerg Surg 37, 511–518 (2011). https://doi.org/10.1007/s00068-011-0073-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00068-011-0073-x